Benzamide

Benzamide

SCHEMBL19667939

NC(=O)c1ccccc1.c1c[nH]nn1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 1/20 0.57
▸ CYP3A4 P08684 1/20 0.57
▸ PARP1 P09874 1/20 0.57
▸ MAPT P10636 1/20 0.57
▸ TSHR P16473 1/20 0.57
▸ CYP2C19 P33261 1/20 0.57
▸ RECQL P46063 1/20 0.57
▸ BLM P54132 1/20 0.57
▸ PMP22 Q01453 1/20 0.57
▸ HSD17B10 Q99714 1/20 0.57
▸ TDP1 Q9NUW8 1/20 0.57
▸ L3MBTL1 Q9Y468 1/20 0.57
▸ PARP10 Q53GL7 8/20 0.46
▸ F7 P08709 1/20 0.43
▸ F3 P13726 1/20 0.43
▸ SARM1 Q6SZW1 1/20 0.43
▸ SIRT2 Q8IXJ6 1/20 0.43
▸ SIRT6 Q8N6T7 1/20 0.43
▸ SIRT1 Q96EB6 1/20 0.43
▸ SIRT3 Q9NTG7 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25170812 0.88 PARP1 (0.47) POLBCYP3A4PARP1MAPTTSHR
Benzophenone SCHEMBL27762502 0.85 ALDH1A1 (0.54) MAPTTDP1L3MBTL1KMT2AALDH1A1
Benzoic Acid SCHEMBL17495601 0.85 NAPRT (0.54) TSHRKMT2AALDH1A1MEN1
Acetophenone SCHEMBL16114519 0.82 SMN1; SMN2 (0.46) MAPTTSHRL3MBTL1KMT2AALDH1A1
SCHEMBL28061261 0.81 KMT2A (0.33) CYP3A4TSHRCYP2C19KMT2AALDH1A1
SCHEMBL27970673 0.81 KMT2A (0.33) CYP3A4TSHRCYP2C19KMT2AALDH1A1
Carbamic Acid SCHEMBL1682079 0.80 — —
SCHEMBL28016232 0.79 MEN1 (0.32) TSHRKMT2AALDH1A1MEN1
Benzoic Acid SCHEMBL380582 0.79 NAPRT (0.47) CYP3A4TSHRCYP2C19TDP1L3MBTL1
Phenylglyoxal SCHEMBL23748334 0.79 ALDH1A1 (0.60) CYP3A4MAPTTSHRRECQLTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104109166-A Quinoline compound, preparation method, intermediate, pharmaceutical composition and application thereof SHANGHAI PHARMACEUTICALS HOLDING CO LTD 2014-10-22 — — CN claimed
CN-1526704-A Substituted triazolformamide compound 拜尔农作物科学股份公司 2004-09-08 — — CN claimed
CN-1200652-A Herbicidal mixtures with synergistic activity BASF AG (DE) 1998-12-02 — — CN claimed
EP-3817811-B1 TRIAZOLE BENZAMIDE DERIVATIVES AS GPR142 AGONISTS BOEHRINGER INGELHEIM INT (DE) 2024-04-03 — — EP disclosed
CN-112368049-B Triazole benzamide derivatives as GPR142 agonists 勃林格殷格翰国际有限公司 2024-03-29 — — CN disclosed
CN-112368049-B Triazole benzamide derivatives as GPR142 agonists 勃林格殷格翰国际有限公司 2024-03-29 — — CN disclosed
CN-114249692-B 2-imidazole benzamide active compound for preventing and treating wheat take-all and wheat stem basal rot 河南农业大学 2024-01-30 — — CN disclosed
US-11179371-B2 Triazole benzamide derivatives as GPR142 agonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-11-23 — — US disclosed
US-11179371-B2 Triazole benzamide derivatives as GPR142 agonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-11-23 — — US disclosed
US-20210230126-A1 ASYMMETRIC TRIAZOLE BENZAMIDE DERIVATIVES AND THE COMPOSITIONS AND METHODS OF TREATMENT REGARDING THE SAME NYSNOBIO IRELAND DAC (IE) 2021-07-29 — — US disclosed
US-20210230126-A1 ASYMMETRIC TRIAZOLE BENZAMIDE DERIVATIVES AND THE COMPOSITIONS AND METHODS OF TREATMENT REGARDING THE SAME NYSNOBIO IRELAND DAC (IE) 2021-07-29 — — US disclosed
CN-1246035-A Sulphonyl urea and adjuvant based solid mixture BASF AG (DE) 2000-03-01 — — CN disclosed
CN-1245487-A Herbicidal 3-aminocarbonyl-or 3-aminothiocarbonyl-substituted 2-benzoylcyclohexane-1, 3-diones BASF AG (DE) 2000-02-23 — — CN disclosed
CN-1245488-A Substituted 2-benzoyl-cyclohexan-1,3-diones with herbicidal effect BASF AG (DE) 2000-02-23 — — CN disclosed
CN-1230951-A Herbicidal heteroaroyl cyclohexanedione derivatives BASF AG (DE) 1999-10-06 — — CN disclosed
CN-1211979-A 2-hetaroylcyclohexane-1,3-diones BASF AG (DE) 1999-03-24 — — CN disclosed
CN-1211249-A Pyrazol-4-yl heteroaroyl derivatives as herbicides BASF AG (DE) 1999-03-17 — — CN disclosed
CN-1200652-A Herbicidal mixtures with synergistic activity BASF AG (DE) 1998-12-02 — — CN disclosed
CN-1194644-A Pyrazol-4-yl-benzoyl derivatives and their use as herbicides BASF AG (DE) 1998-09-30 — — CN disclosed
CN-1194641-A 2-cyclohexane-1,3-dione benzoyl derivatives BASF AG (DE) 1998-09-30 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11179371-B2 Triazole benzamide derivatives as GPR142 agonists GPR119, GPR142, GPR65 POLB 4750/4885CYP3A4 1194/4885PARP1 3101/4885
US-20210230126-A1 ASYMMETRIC TRIAZOLE BENZAMIDE DERIVATIVES AND THE COMPOSITIONS AND METHODS OF TREATMENT REGARDING THE SAME ATG7, PINK1, ADRM1 POLB 1629/4885CYP3A4 1419/4885PARP1 328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback